Christopher Lipinski - The Lyn kinase activator MLR-1023 is a novel insulin receptor potentiator that elicits a rapid-onset and durable improvement in glucose homeostasis in animal models of type 2 diabetes

Document created by Christopher Lipinski on Aug 22, 2014
Version 1Show Document
  • View in full screen mode

  Publication Details (including relevant citation   information): Ochman, Alexander R., Lipinski,   Christopher A., Handler, Jeffrey A., Reaume, Andrew G., Saporito,   Michael S., Journal of Pharmacology and Experimental   Therapeutics, 2012, 342 (1), pp   23-32

  Abstract: null

  Address (URL):